Related Experiment Video
Updated: Aug 13, 2025

Restraint to Induce Stress in Mice and Rats
Published on: December 6, 2024
Recent Studies on the Development of Nicotine Abuse and Behavioral Changes Induced by Chronic Stress Depending on
Karolina Grabowska1, Wojciech Ziemichód1, Grażyna Biała1
1Chair and Department of Pharmacology with Pharmacodynamics, Medical University of Lublin, Chodźki 4A Street, 20-400 Lublin, Poland.
Abstract:
Nowadays, stressful situations are an unavoidable element of everyday life. Stressors activate a number of complex mental and physiological reactions in the organism, thus affecting the state of health of an individual. Stress is the main risk factor in the development of mental disorders, such as depression and other disorders developing as a result of addiction. Studies indicate that women are twice as likely as men to develop anxiety, depression and therefore addiction, e.g., to nicotine. Even though the data presented is indicative of significant differences between the sexes in the prevalence of these disorders, the majority of preclinical animal models for investigating stress-induced disorders use predominantly male subjects. However, the recent data indicates that this type of studies has also been launched in female rodents. Therefore, conducting research on both sexes allows for a more accurate understanding and assessment of the impact of stress on stress-induced behavioral, peripheral and molecular changes in the body and brain. In this manuscript we have gathered the data from 41 years (from 1981-2022) on the influence of stress on the development of depression and nicotine addiction in both sexes.
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Introduction to Stress and Lifestyle
Psychological Responses to Stress
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

